The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus

Abstract

The aim of this article is to compare the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in systemic lupus erythematosus (SLE) patients with and without arthritis and in patients with rheumatoid arthritis (RA). Anti-CCP antibodies were measured using ELISA in 159 SLE patients with arthritis (12 patients with erosive arthritis), 108 SLE patients without arthritis, 76 RA patients, and 87 healthy subjects (controls). The following had anti-CCP antibodies above the cut-off level (5 U/ml): 27.3% of SLE patients, 42.1% SLE patients with arthritis, 5.6% SLE patients without arthritis, 85.5% RA patients and 1.1% controls. The mean titre of anti-CCP antibodies in the SLE group was much lower than that in the RA group (33 ± 72 vs. 160 ± 125 U/ml), but higher in SLE patients with erosive arthritis than those with non-erosive arthritis (221 ± 88 vs. 32 ± 42 U/ml). Hand poly-arthritis occurred more frequently in anti-CCP-positive SLE patients with erosive arthritis than those with non-erosive arthritis. Anti-CCP antibodies were prevalent in some SLE patients, more prevalent in SLE patients with arthritis than those without arthritis. Anti-CCP-positive SLE patients were more likely associated with hand poly-arthritis, and high titre of anti-CCP antibodies might be used as a predictor for the complication of erosive arthritis.

Keywords

anti-CCP antibodies arthritis erosive arthropathy systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Nishimura K Sugiyama D Kagata Y . Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146: 797–808.

2 Alenius GM Berglin E Rantapaa Dahlqvist S . Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 2006; 65: 398–400.

3 Korendowych E Owen P Ravindran J Carmichael C McHugh N . The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford) 2005; 44: 1056–1060.

4 Mediwake R Isenberg DA Schellekens GA van Venrooij WJ . Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001; 60: 67–68.

5 Martinez JB Valero JS Bautista AJ . Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 2007; 25: 47–53.

6 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

7 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40: 1725.

8 Arnett FC Edworthy SM Bloch DA . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.

9 Rantapää-Dahlqvist S de Jong BA Berglin E . Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–2749.

10.

10 Schellekens GA Visser H de Jong BA . The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–163.

11.

11 Avouac J Gossec L Dougados M . Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006; 65: 845–851.

12.

12 Kasapçopur O Altun S Aslan M . Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1687–1689.

13.

13 Renaudineau Y Croquefer S Jousse S . Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 2006; 54: 2523–2532.

14.

14 Somers E Magder LS Petri M . Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2531–2536.

15.

15 McCauliffe DP . Cutaneous diseases in adults associated with anti-Ro/SS-A autoantibody production. Lupus 1997; 6: 158–166.

16.

16 Buyon JP Winchester RJ Slade SG . Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1263–1273.

17.

17 Alarcón-Segovia D Abud-Mendoza C Diaz-Jouanen E Iglesias A De los Reyes V Hernández-Ortiz J . Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol 1988; 15: 65–69.

18.

18 Reilly PA Evison G McHugh NJ Maddison PJ . Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol 1990; 17: 777–784.

19.

19 Damian-Abrego GN Cabiedes J Cabral AR . Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 2007; 17: 300–304.

20.

20 Chan MT Owen P Dunphy J . Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 2008; 35: 77–83.

21.

21 Labowitz R Schumacher HRJ . Articular manifestations of systemic lupus erythematosus. Ann Intern Med 1971; 74: 9211–9221.

22.

22 Richter Cohen M Steiner G Smolen JS Isenberg DA . Erosive arthritis in systemic lupus erythematosus: analysis of distinct clinical and serological subset. Rheumatology (Oxford) 1998; 37: 421–424.

23.

23 van der Helm-van Mil A Verpoort K Breedveld F Toes R Huizinga T . Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R949–R958.

24.

24 Simon JA Granados J Cabiedes J Morales JR Varela JA . Clinical and immunogenetic characterization of Mexican patients with ‘rhupus’. Lupus 2002; 11: 315–324.